Cargando…
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
miR-125b, ubiquitously expressed and frequently dysregulated in several tumors, has gained special interest in the field of cancer research, displaying either oncogenic or oncosuppressor potential based on tumor type. We have previously demonstrated its tumor-suppressive role in multiple myeloma (MM...
Autores principales: | Misso, Gabriella, Zarone, Mayra Rachele, Lombardi, Angela, Grimaldi, Anna, Cossu, Alessia Maria, Ferri, Carmela, Russo, Margherita, Vuoso, Daniela Cristina, Luce, Amalia, Kawasaki, Hiromichi, Di Martino, Maria Teresa, Virgilio, Antonella, Festa, Agostino, Galeone, Aldo, De Rosa, Giuseppe, Irace, Carlo, Donadelli, Massimo, Necas, Alois, Amler, Evzen, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Caraglia, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479071/ https://www.ncbi.nlm.nih.gov/pubmed/31009917 http://dx.doi.org/10.1016/j.omtn.2019.02.023 |
Ejemplares similares
-
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
por: Zarone, Mayra Rachele, et al.
Publicado: (2017) -
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
por: Scognamiglio, Immacolata, et al.
Publicado: (2014) -
Mir-34: A New Weapon Against Cancer?
por: Misso, Gabriella, et al.
Publicado: (2014) -
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
por: Amodio, Nicola, et al.
Publicado: (2015) -
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer
por: Abate, Marianna, et al.
Publicado: (2023)